drugset / Trial / NCT01115322

A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

NCT01115322

Phase 1 Completed 38 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedParallel-groupSingle-blindBasic science

Summary

The purpose of this study is to evaluate the potential of Tazarotene Foam to induce a phototoxic reaction when exposed to UV and VIS light on skin of healthy volunteers.

Timeline

Start
2010-04-01
Primary completion
2010-04-10
Completion
2010-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tazarotene Small molecule 0.1 % Topical

Indications